A PHASE 1 DOSE ESCALATION STUDY EVALUATING THE SAFETY AND TOLERABILITY OF PF 06804103 IN PATIENTS WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) POSITIVE AND NEGATIVEe SOLID TUMORS

  • Sabanathan, Dhanusha, (Primary Chief Investigator)
  • Chapman, Nicola, (Clinical Trial Unit Staff)

Project: Research

Project Details

AcronymC0541001
StatusActive
Effective start/end date21/09/2031/05/25